Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors.

Janoshazi A, Deraet M, Callebert J, Setola V, Guenther S, Saubamea B, Manivet P, Launay JM, Maroteaux L.

Mol Pharmacol. 2007 Jun;71(6):1463-74. Epub 2007 Feb 26.

3.

The natural mutation encoding a C terminus-truncated 5-hydroxytryptamine 2B receptor is a gain of proliferative functions.

Deraet M, Manivet P, Janoshazi A, Callebert J, Guenther S, Drouet L, Launay JM, Maroteaux L.

Mol Pharmacol. 2005 Apr;67(4):983-91. Epub 2004 Dec 29.

4.

Methionine proximity assay, a novel method for exploring peptide ligand-receptor interaction.

Rihakova L, Deraët M, Auger-Messier M, Pérodin J, Boucard AA, Guillemette G, Leduc R, Lavigne P, Escher E.

J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):297-313.

PMID:
12503623
5.

Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor.

Pérodin J, Deraët M, Auger-Messier M, Boucard AA, Rihakova L, Beaulieu ME, Lavigne P, Parent JL, Guillemette G, Leduc R, Escher E.

Biochemistry. 2002 Dec 3;41(48):14348-56.

PMID:
12450401
6.

Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in an extended form.

Deraët M, Rihakova L, Boucard A, Pèrodin J, Sauvé S, Mathieu AP, Guillemette G, Leduc R, Lavigne P, Escher E.

Can J Physiol Pharmacol. 2002 May;80(5):418-25.

PMID:
12056548

Supplemental Content

Loading ...
Support Center